Christiane Chéreau

No ORCID on file · 7 papers in corpus · active 2009-2016

Study types

  • article 6
  • other 1

Condition tags

  • endometriosis 7
  • die_deep_infiltrating 2
  • chronic_pelvic_pain 1
  • infertility 1
article 2016
Expert opinion on therapeutic targets ·doi:10.1080/14728222.2016.1180367

OBJECTIVE: Mitogen-activated protein kinases (MAPKs) are involved in the proliferation and survival of endometriotic lesions. Vemurafenib (PLX4032) is a novel protein kinase inhibitor that targets BRAF, a member of the MAPK pathway. The pre…

article 2014
Journal of reproductive immunology ·doi:10.1016/j.jri.2013.12.121
article 2011
The American journal of pathology ·doi:10.1016/j.ajpath.2011.04.020
article 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.09.031
other 2010
The American journal of pathology ·doi:10.2353/ajpath.2010.100375

Deep infiltrating endometriosis (DIE) is characterized by chronic pain, hyperproliferation of endometriotic cells and fibrosis. Since cannabinoids are endowed with antiproliferative and antifibrotic properties, in addition to their psychoge…

article 2010
The Journal of Pathology ·doi:10.1002/path.2756

Endometriosis affects 6-10% of women in their reproductive years, causing chronic pelvic pain and infertility. Its pathogenesis remains poorly understood and current treatments, based on hormonal therapy or surgery, are often insufficient. …

article 2009
The American journal of pathology ·doi:10.2353/ajpath.2009.080804